ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 35 filers reported holding ATYR PHARMA INC in Q3 2022. The put-call ratio across all filers is 5.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,060 | -50.5% | 78,519 | -32.3% | 0.00% | – |
| Q2 2023 | $250,407 | +68.9% | 115,929 | +64.2% | 0.00% | – |
| Q1 2023 | $148,271 | +47.6% | 70,605 | +53.9% | 0.00% | – |
| Q4 2022 | $100,457 | -27.2% | 45,871 | 0.0% | 0.00% | – |
| Q3 2022 | $138,000 | +6.2% | 45,871 | 0.0% | 0.00% | – |
| Q2 2022 | $130,000 | -45.4% | 45,871 | +3.3% | 0.00% | – |
| Q1 2022 | $238,000 | -28.3% | 44,406 | 0.0% | 0.00% | – |
| Q4 2021 | $332,000 | +48.2% | 44,406 | +80.0% | 0.00% | – |
| Q3 2021 | $224,000 | +76.4% | 24,673 | -5.5% | 0.00% | – |
| Q2 2021 | $127,000 | +29.6% | 26,105 | +18.5% | 0.00% | – |
| Q1 2021 | $98,000 | +15.3% | 22,033 | +0.4% | 0.00% | – |
| Q4 2020 | $85,000 | +26.9% | 21,946 | +6.2% | 0.00% | – |
| Q3 2020 | $67,000 | -27.2% | 20,658 | 0.0% | 0.00% | – |
| Q2 2020 | $92,000 | – | 20,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |